Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin up-titration in Chinese patients with type 2 diabetes mellitus: study design and rationale of the vision study

被引：0
|
作者：
Li-Nong Ji
Chang-Yu Pan
Ju-Ming Lu
Hong Li
Qiang Li
Qi-Fu Li
Yong-De Peng
Hao-Ming Tian
Chen Yao
Zhi-Gang Zhao
Ru-Ya Zhang
Xiang-Ling Wang
Lei Wang
机构：
[1] Peking University People’s Hospital,
[2] 11 Xizhimen Nan Dajie,undefined
[3] Chinese PLA General Hospital,undefined
[4] Sir Run Run Shaw Hospital,undefined
[5] Zhejiang University Medical College,undefined
[6] The 2nd Affiliated Hospital of Harbin Medical University,undefined
[7] The First Affiliated Hospital of Chongqing Medical University,undefined
[8] Shanghai First People's Hospital,undefined
[9] West China Hospital,undefined
[10] Sichuan University,undefined
[11] Peking University First Hospital,undefined
[12] Henan Provincial People's Hospital,undefined
[13] Beijing Novartis Pharma Co. Ltd,undefined
来源：
Cardiovascular Diabetology | / 12卷
关键词：
VISION study; Vildagliptin; Type 2 diabetes; Study design; DPP-IV inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Efficacy and Safety of Gosogliptin as Monotherapy and in Combination with Metformin in Patients with Type 2 Diabetes Mellitus
    Trakhtenberg, Julia
    Vostokova, Natalia
    Karavaeva, Oksana
    Kreminskaya, Vera
    Ametov, Alexander
    DIABETES, 2015, 64 : A329 - A330
  • [22] A comparison of efficacy and safety of vildagliptin and gliclazide in combination with metformin in patients with Type 2 diabetes inadequately controlled with metformin alone: a 52-week, randomized study
    Filozof, C.
    Gautier, J. -F.
    DIABETIC MEDICINE, 2010, 27 (03) : 318 - 326
  • [23] ECONOMIC EVALUATION OF SAXAGLIPTIN IN COMBINATION WITH METFORMIN VERSUS SITAGLIPTIN OR VILDAGLIPTIN IN COMBINATION WITH METFORMIN IN PATIENTS WITH TYPE 2 DIABETES IN RUSSIA
    Krysanov, I
    Tiapkina, M.
    VALUE IN HEALTH, 2015, 18 (07) : A608 - A608
  • [24] A Comparative Study of Safety and Efficacy of Metformin Monotherapy Against Teneligliptin and Metformin in Type 2 Diabetes Mellitus
    Poornima, R.
    Brigida, S.
    Elizabeth, Arul Amutha
    Soujania, G.
    Lella, Tanuja
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 (02) : 7 - 12
  • [25] Efficacy of insulin-metformin combination therapy in patients with type 2 diabetes mellitus
    Jaber, LA
    Slaughter, RL
    DIABETES, 1998, 47 : A88 - A88
  • [26] Evaluating the Efficacy, Safety, and Tolerability of Combination Therapy of Dapagliflozin and Linagliptin Over Dapagliflozin and Vildagliptin in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
    Dharmalingam, Mala
    Sharma, Surendra Kumar
    Prakash, Ved
    Maiti, Animesh
    Kumar, Ritesh
    Murthy, Laxminarayanappa Sreenivasa S.
    Ramanathan, Balamurugan
    Maheshwari, Sanjiv
    Kethavath, Sunil Naik
    Ogale, Dhananjay
    Bachubhai, Prajapati Vipul Kumar
    Sonawane, Ashutosh B.
    Shah, Vaishal
    Suresh, Manjula
    Chakraborty, Sisir
    Manjunath, Krishna Kumar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [27] Effect of Vildagliptin and Metformin Combination Therapy on Liver Fat Content in Type 2 Diabetes Mellitus
    Chen, Zaoping
    Liu, Jun
    Hang, Xinmei
    DIABETES, 2015, 64 : A508 - A508
  • [28] Early initiation of sitagliptin during metformin up-titration in treatment of patients with type 2 diabetes
    Frias, J. P.
    Zimmer, Z.
    Lam, R. L. H.
    Amorin, G.
    Ntabadde, C.
    Iredale, C.
    O'Neill, E. A.
    Engel, S. S.
    Kaufman, K. D.
    Makimura, H.
    Crutchlow, M. F.
    DIABETOLOGIA, 2018, 61 : S379 - S379
  • [29] Safety and Efficacy of Pioglitazone/Metformin Combination Therapy in Treatment of Type 2 Diabetes: A Rationale for Earlier Use
    Stolar, Mark
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 289 - 303
  • [30] Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
    Das, Sambit
    Gupta, A. K.
    Bandhopa, Biplab
    Darla, B. Harish
    Arya, Vivek
    Abhyankar, Mahesh
    Revankar, Santosh
    BIOINFORMATION, 2021, 17 (03) : 413 - 423
12345